LCM
PGNX

Laurion Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Laurion Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,270
Closed -$62K – 825
2016
Q1 		$62K Buy
+14,270
New +$62K ﹤0.01% 463